Koyfin Home > Directory > Health Care > Nymox Pharm Corp > EBIT

Nymox Pharm Corp EBIT Chart (NYMX)

Nymox Pharm Corp annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Nymox Pharm Corp EBIT for the quarter ending June 06, 2020 was $-3m a 14.53% decrease of 0m year over year
  • Nymox Pharm Corp EBIT for the last 12 months ending June 06, 2020 was $-11m a -24.17% increase of 3m year over year
  • Nymox Pharm Corp Annual EBIT for 2019 was $-13m a 20.14% decrease of -3m from 2018
  • Nymox Pharm Corp Annual EBIT for 2018 was $-11m a -24.38% increase of 3m from 2017
  • Nymox Pharm Corp Annual EBIT for 2017 was $-13m a 2.77% decrease of 0m from 2016
Other Income Statement Metrics:
  • Nymox Pharm Corp EBITDA for the quarter ending September 09, 2018 was $-3m a -17.77% increase of 0m year over year
  • Nymox Pharm Corp Net Income for the quarter ending September 09, 2018 was $-3m a -19.24% increase of 1m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX EBIT Data

06/2020$-3m
03/2020$-3m
12/2019$-3m
09/2019$-3m
06/2019$-5m
03/2019$-3m
12/2018$-3m
09/2018$-3m
06/2018$-2m
03/2018$-3m

Annual NYMX EBIT Data

2019$-13m
2018$-11m
2017$-13m
2016$-13m
2015$-18m
2014$-5m
2013$-5m
2012$-8m
2011$-10m
2010$-7m